These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34100380)

  • 1. Tripartite motif containing 28 (TRIM28) promotes the growth and migration of endometrial carcinoma cells by regulating the AKT/mTOR signaling pathway.
    Chen Y; Cheng H; Long H
    Gen Physiol Biophys; 2021 May; 40(3):245-252. PubMed ID: 34100380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
    Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
    Gynecol Oncol; 2019 Jul; 154(1):207-217. PubMed ID: 30979588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat Shock Protein B7 Inhibits the Progression of Endometrial Carcinoma by Inhibiting PI3K/AKT/mTOR Pathway.
    Xing M; Wu B; Wang S
    Reprod Sci; 2023 Feb; 30(2):590-600. PubMed ID: 35859224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer.
    Fan Y; Dong Z; Shi Y; Sun S; Wei B; Zhan L
    J Int Med Res; 2020 May; 48(5):300060520925352. PubMed ID: 32431202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
    Zhang S; Wang M; Li Q; Zhu P
    Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.
    Li F; Wang Z; Lu G
    Oncol Rep; 2018 Apr; 39(4):1860-1866. PubMed ID: 29393469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
    Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
    Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZNF488 Promotes the Invasion and Migration of Pancreatic Carcinoma Cells through the Akt/mTOR Pathway.
    Qiu H; Zhang L; Wang D; Zhang Y; Cai H; Miao H; Chu F
    Comput Math Methods Med; 2022; 2022():4622877. PubMed ID: 35111235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
    Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
    Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway.
    Bao XY; Sun M; Peng TT; Han DM
    Cancer Biomark; 2021; 31(4):307-315. PubMed ID: 33896816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
    Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
    Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway.
    Hou X; Zhao M; Wang T; Zhang G
    Oncol Rep; 2014 Mar; 31(3):1175-82. PubMed ID: 24366110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
    Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
    EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LTB4R Promotes the Occurrence and Progression of Clear Cell Renal Cell Carcinoma (ccRCC) by Regulating the AKT/mTOR Signaling Pathway.
    Zhang X; Wu H; Yan X; Ma J; Chen Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FKBP38 suppresses endometrial cancer cell proliferation and metastasis by inhibiting the mTOR pathway.
    Yan Y; Wang S; Zhang Z; Tang M; Zhao AZ; Li Z; Wu X; Li F
    Arch Biochem Biophys; 2024 Feb; 752():109891. PubMed ID: 38218360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.